INVA Dec 2024 12.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:28PM EDT. Market open.
| Previous close | 3.7000 |
| Open | 3.7000 |
| Bid | 3.4000 |
| Ask | 5.5000 |
| Strike | 12.50 |
| Expiry date | 2024-12-20 |
| Day's range | 3.7000 - 3.7000 |
| Contract range | N/A |
| Volume | |
| Open interest | 3 |
Simply Wall St.Calculating The Fair Value Of Innoviva, Inc. (NASDAQ:INVA)
Key Insights Innoviva's estimated fair value is US$19.59 based on 2 Stage Free Cash Flow to Equity Current share price...
Business WireInnoviva to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
BURLINGAME, Calif., June 03, 2024--Innoviva, Inc. (Nasdaq: INVA) ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics ("IST"), and a portfolio of strategic investments in healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, FL
- GuruFocus.com
Innoviva Inc (INVA) Reports First Quarter 2024 Earnings: A Detailed Analysis
Strong Performance with Significant Growth in Net Product Revenue
© 2024 Yahoo. All rights reserved.